热门资讯> 正文
Vivos Therapeutics宣布以430万美元注册直接发行普通股
2024-09-19 19:53
- Vivos Therapeutics (NASDAQ:VVOS) has entered into agreement for direct offering of an aggregate of 1.36M common shares at $3.15 per share for gross proceeds of ~$4.3M
- Closing date is September 20.
- The net proceeds will be used for the offering for working capital and general corporate purposes.
- VVOS -21.5% premarket to $3.24
- Source: Press Release
More on Vivos Therapeutics
- Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript
- Vivos surges on FDA nod for pediatric sleep apnea device
- Vivos gains as pilot program validates new market model
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
- Historical earnings data for Vivos Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
